Child Opportunity Index and Survival After Pediatric Hematopoietic Cell Transplantation for Acute Leukemia.
BACKGROUND: Despite advances in pediatric hematopoietic cell transplantation (HCT) for acute leukemia, many children still experience relapse and non-relapse mortality (NRM). 7%) were higher among those in very low opportunity neighborhoods but were not statistically significant.
BACKGROUND: Despite advances in pediatric hematopoietic cell transplantation (HCT) for acute leukemia, many children still experience relapse and non-relapse mortality (NRM). 7%) were higher among those in very low opportunity neighborhoods but were not statistically significant.
What the study was
- Study design
- Retrospective Study
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Transplant Cell Ther
Why it surfaced
Affirmative clinical guideline or practice recommendation language present; Topic: Hematologic malignancies; Score 6/10 → STANDARD priority
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.